Hypercalcemia in Malignancy and Chronic Kidney Disease

Primary Mechanisms

• The National Kidney Foundation's K/DOQI guidelines emphasize that CKD itself typically causes hypocalcemia, not hypercalcemia, through impaired conversion of 25-hydroxyvitamin D to 1,25(OH)2D, phosphate retention, and skeletal PTH resistance 2, 3.

Mechanisms in Chronic Kidney Disease

• Calcium-based phosphate binders combined with vitamin D analogs cause hypercalcemia in 22.6-43.3% of CKD patients 1.
• Patients with low-turnover bone disease are particularly susceptible to hypercalcemia from calcium supplementation because their bones cannot buffer calcium loads 4.

Diagnostic Approach

• Measure intact PTH, albumin-corrected calcium, and ionized calcium to distinguish PTH-mediated from non-PTH-mediated causes 1.
• Use the formula: Corrected calcium (mg/dL) = Total calcium + 0.8 × [4.0 - Serum albumin (g/dL)] [2, 1].

Critical Pitfalls to Avoid

• Do not rely on corrected calcium alone—measure ionized calcium to avoid pseudo-hypercalcemia from hemolysis or improper sampling 1.
• Never assume CKD itself causes hypercalcemia—it causes hypocalcemia; elevated calcium in CKD patients indicates iatrogenic causes or tertiary hyperparathyroidism 2, 3.